Back
Sarepta Therapeutics Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
129.47
Seasonality Move:
17.56%
Buy
57
BMRN
Biomarin Pharmaceutical
Last Price:
87.35
Seasonality Move:
2.33%
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.21. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $88.63. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.21
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $88.63
The current trend is relatively stagnant and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.79 | Buy |
Relative Strength Index (14 RSI): | 59.93 | Buy |
Chaikin Money Flow: | 464730 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.45 - 133.09) | Buy |
Bollinger Bands (100): | (88.54 - 127.5) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.51 | Sell |
Relative Strength Index (14 RSI): | 58.26 | Buy |
Chaikin Money Flow: | 638522 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (84.53 - 88.79) | Buy |
Bollinger Bands (100): | (85.23 - 94.71) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 126.62 | Buy |
20-day SMA: | 124.69 | Buy |
50-day SMA: | 125.43 | Buy |
200-day SMA: | 111.12 | Buy |
8-day EMA: | 127.15 | Buy |
20-day EMA: | 126.2 | Buy |
50-day EMA: | 122.44 | Buy |
200-day EMA: | 114.33 | Buy |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.75 | Buy |
20-day SMA: | 85.8 | Buy |
50-day SMA: | 88.22 | Buy |
200-day SMA: | 89.3 | Sell |
8-day EMA: | 86.42 | Buy |
20-day EMA: | 86.37 | Buy |
50-day EMA: | 87.93 | Buy |
200-day EMA: | 89.96 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.15 per share, an increase next quarter of $1.44 per share, an increase this year of $5.52 per share, and an increase next year of $8.95 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.10 per share, an increase this year of $0.81 per share, and an increase next year of $0.98 per share.
Sarepta Therapeutics Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |